JP2005515199A - チック障害の治療のためのノルエピネフリン再取込インヒビターの使用 - Google Patents

チック障害の治療のためのノルエピネフリン再取込インヒビターの使用 Download PDF

Info

Publication number
JP2005515199A
JP2005515199A JP2003548816A JP2003548816A JP2005515199A JP 2005515199 A JP2005515199 A JP 2005515199A JP 2003548816 A JP2003548816 A JP 2003548816A JP 2003548816 A JP2003548816 A JP 2003548816A JP 2005515199 A JP2005515199 A JP 2005515199A
Authority
JP
Japan
Prior art keywords
norepinephrine reuptake
tic
use according
reuptake inhibitor
atomoxetine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003548816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515199A5 (enExample
Inventor
アルバート・ジョン・アレン
デイビッド・マイケルソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JP2005515199A publication Critical patent/JP2005515199A/ja
Publication of JP2005515199A5 publication Critical patent/JP2005515199A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2003548816A 2001-11-30 2002-11-12 チック障害の治療のためのノルエピネフリン再取込インヒビターの使用 Pending JP2005515199A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33449401P 2001-11-30 2001-11-30
PCT/US2002/033628 WO2003047560A1 (en) 2001-11-30 2002-11-12 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders

Publications (2)

Publication Number Publication Date
JP2005515199A true JP2005515199A (ja) 2005-05-26
JP2005515199A5 JP2005515199A5 (enExample) 2006-01-05

Family

ID=23307469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003548816A Pending JP2005515199A (ja) 2001-11-30 2002-11-12 チック障害の治療のためのノルエピネフリン再取込インヒビターの使用

Country Status (12)

Country Link
US (2) US20050014843A1 (enExample)
EP (1) EP1455770B1 (enExample)
JP (1) JP2005515199A (enExample)
KR (1) KR20050044604A (enExample)
AT (1) ATE365035T1 (enExample)
AU (1) AU2002347984A1 (enExample)
CA (1) CA2466649A1 (enExample)
DE (1) DE60220825T2 (enExample)
DK (1) DK1455770T3 (enExample)
ES (1) ES2287338T3 (enExample)
PT (1) PT1455770E (enExample)
WO (1) WO2003047560A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
JP2005522445A (ja) * 2002-02-12 2005-07-28 サイプレス バイオサイエンス， インコーポレイテッド 注意欠陥過活動性障害（ａｄ／ｈｄ）の処置方法
WO2005060949A2 (en) * 2003-12-12 2005-07-07 Eli Lilly And Company Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
WO2006077846A1 (ja) * 2005-01-18 2006-07-27 Mitsubishi Pharma Corporation 注意欠陥/多動性障害治療薬
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20080031932A1 (en) * 2006-08-04 2008-02-07 Watson Laboratories, Inc. Transdermal atomoxetine formulations and associated methods
KR102096165B1 (ko) 2018-05-03 2020-04-01 노충구 틱 장애 개선 및 치료 효과를 가지는 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
US6323242B1 (en) * 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
ES2258010T3 (es) * 1999-07-01 2006-08-16 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar el dolor cronico.
PT1257277E (pt) * 2000-02-24 2005-09-30 Pharmacia & Upjohn Co Llc Novas combinacoes de farmacos
JP2004517112A (ja) * 2001-01-02 2004-06-10 ファルマシア・アンド・アップジョン・カンパニー 新規薬物コンビネーション

Also Published As

Publication number Publication date
PT1455770E (pt) 2007-09-06
EP1455770B1 (en) 2007-06-20
DE60220825D1 (de) 2007-08-02
WO2003047560A1 (en) 2003-06-12
DE60220825T2 (de) 2008-03-06
CA2466649A1 (en) 2003-06-12
DK1455770T3 (da) 2007-10-08
US20080200555A1 (en) 2008-08-21
EP1455770A1 (en) 2004-09-15
ATE365035T1 (de) 2007-07-15
ES2287338T3 (es) 2007-12-16
AU2002347984A1 (en) 2003-06-17
KR20050044604A (ko) 2005-05-12
US20050014843A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
US6184222B1 (en) Treatment of conduct disorder
KR20010024218A (ko) 반항성 장애의 치료
US20080200555A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
US20050009925A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
BRPI0616659A2 (pt) droga terapÊutica antituberculose, medicamento, e, kit para o tratamento de tuberculose
AU2002217757A1 (en) Treatment of anxiety disorders
US20230390223A1 (en) Administration of antipurinergic compositions for treating nervous system disorders
SK14502000A3 (sk) Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu
US20040034106A1 (en) Treatment of anxiety disorders
WO1999025355A1 (en) Method of treating addiction to nicotine products
JP4728257B2 (ja) セロトニン再取込み阻害薬およびイミダゾリンｉ２作動薬の組み合わせ
NZ540415A (en) Use of levocetirizine for the treatment of persistent allergic rhinitis
MXPA00002829A (en) Treatment of conduct disorder
MXPA00002837A (en) Treatment of oppositional defiant disorder

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051110

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080911

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081111

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090714